Covered recipient · General Payments record
ADRIENNE E BROUSSARD
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2022–2024
$1,361.55
- Reported across 79 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $346.53 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $167.63 | 15 |
| GENZYME CORPORATION | $84.90 | 5 |
| AERIN MEDICAL INC. | $22.41 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $20.67 | 1 |
| OptiNose US, Inc. | $20.47 | 1 |
| Regeneron Healthcare Solutions, Inc. | $17.08 | 1 |
| Acerta Pharma LLC | $13.37 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.48 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106830526 | CMS |
| ABBVIE INC. | $0.80 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106830528 | CMS |
| ABBVIE INC. | $16.92 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106830530 | CMS |
| ABBVIE INC. | $26.13 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106830532 | CMS |
| ABBVIE INC. | $29.32 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106830534 | CMS |
| ABBVIE INC. | $8.47 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106830536 | CMS |
| ABBVIE INC. | $12.66 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106830538 | CMS |
| ABBVIE INC. | $1.13 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106830540 | CMS |
| ABBVIE INC. | $9.13 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106830542 | CMS |
| ABBVIE INC. | $4.45 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106830544 | CMS |
| ABBVIE INC. | $15.53 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106830546 | CMS |
| ABBVIE INC. | $17.18 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106830548 | CMS |
| ABBVIE INC. | $4.16 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106830550 | CMS |
| ABBVIE INC. | $6.58 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106830552 | CMS |
| ABBVIE INC. | $0.69 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106830554 | CMS |
| AERIN MEDICAL INC. | $22.41 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144645869 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.37 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105828721 | CMS |
| GENZYME CORPORATION | $16.66 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139972859 | CMS |
| GENZYME CORPORATION | $15.17 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139972885 | CMS |
| GENZYME CORPORATION | $20.55 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139972899 | CMS |
| GENZYME CORPORATION | $16.01 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139972919 | CMS |
| GENZYME CORPORATION | $16.51 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139972933 | CMS |
| Novartis Pharmaceuticals Corporation | $20.67 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086770455 | CMS |
| Optinose US, Inc. | $20.47 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142191490 | CMS |
| Regeneron Healthcare Solutions, Inc. | $17.08 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114277415 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.